Aranscia acquires select assets of YouScript from Invitae, terms not disclosed

Aranscia, a global provider of diagnostics software, services, and testing solutions, and Invitae Corporation announced that Aranscia has acquired select assets of the YouScript personalized medication management platform from Invitae Corporation in an all-cash transaction. YouScript is a player in providing actionable, real-time medication risk and pharmacogenomics insights that enable healthcare providers and organizations to build, deliver, and scale comprehensive personalized medication management programs. YouScript will join the Aranscia portfolio of companies, each of which shares a synergistic mission of solving the tactical gaps in clinical workflows and democratizing access to the promises of precision medicine. This portfolio includes 2bPrecise, the award-winning suite of lab-agnostic, EMR-integrated solutions for PGx, population health insights, and precision oncology workflows; SinguLab, a national network of diagnostics services support; and AccessDx Laboratory, a CLIA-certified, CAP accredited, and NYCQ molecular diagnostic laboratory with specialist expertise in PGx operations. “We warmly welcome the YouScript team and platform to the Aranscia family,” said Joe Spinelli, Chief Strategy Officer of Aranscia. “As one of the foundational innovators in PGx, YouScript has long served as a model contributor to advancing the practical utilization of PGx for clinical professionals as well as measuring the profound impact of PGx programs in improving overall healthcare outcomes. We’re committed to supporting the continued success of YouScript at Aranscia and look forward to collaboration with our other portfolio assets to help YouScript efficiently support clinical PGx programs for providers and organizations around the world.”